Comparative Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Proposed Biosimilar Insulin Glargine and Lantus (R) in Patients with Type 1 Diabetes (T1D)

Heise, T; Tagore, R; Donnelly, C; Barve, A; Jacob, A

DIABETES, 2017; 66 ( ): A268